PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Thursday reported a loss of $68 million in its first quarter.
On a per-share basis, the Pasadena, California-based company said it had a loss of $1.11.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $12.8 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $26 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
